简体中文 | 繁體中文 | English

CONVIDIEN

Covidien to Host Investor Meeting on September 10, 2009

2009-08-12 11:31
  • zh_cn
  • zh_hant
  • en

 

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will host an investor meeting on Thursday, September 10, 2009, to update the investment community on the Company and its growth initiatives, strategic priorities and financial outlook. The event will be held at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY, and will begin at 11:00 am with a management reception. A webcast of the presentations will begin at 12:00 pm and the webcast will conclude by 5:00 pm.

The program will include presentations by Covidien's Chairman, President and CEO Richard J. Meelia, as well as other members of the senior management team. In addition, the meeting will feature interactive physician panels discussing the latest developments in several of the Company’s key product lines.

10:30   Registration opens
11:00 Reception with Executive Management
12:00 Presentations
Richard J. Meelia, Chairman, President and CEO
Select Business Unit Medical Officers and R&D Executives
Interactive physician panels
4:00 Charles Dockendorff, Chief Financial Officer

Advanced registration is required and attendance will be limited to those who register in advance. To register for the meeting, please go to the following website: http://www.zoomerang.com/Survey/?p=WEB229E63UWBLV

Individuals who are unable to attend the meeting in person will be able to view a live video and webcast at Covidien’s website: http://investor.covidien.com. A replay of the presentations and the presentation materials will be available at the same website following the conclusion of the meeting.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

Contacts

Covidien
Eric Kraus, 508-261-8305
Senior Vice President,
Communications
eric.kraus@covidien.com
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Brian Nameth, 508-452-4363
Director
Investor Relations
brian.nameth@covidien.com